These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Rifampin and ansamycin interactions with cyclosporine after renal transplantation. Vandevelde C; Chang A; Andrews D; Riggs W; Jewesson P Pharmacotherapy; 1991; 11(1):88-9. PubMed ID: 2020617 [TBL] [Abstract][Full Text] [Related]
4. Interactions of cyclosporine with antimicrobial agents. Sands M; Brown RB Rev Infect Dis; 1989; 11(5):691-7. PubMed ID: 2682943 [TBL] [Abstract][Full Text] [Related]
5. Acute rejection and massive cyclosporine requirements in heart transplant recipients treated with rifampin. Modry DL; Stinson EB; Oyer PE; Jamieson SW; Baldwin JC; Shumway NE Transplantation; 1985 Mar; 39(3):313-4. PubMed ID: 3883596 [No Abstract] [Full Text] [Related]
6. Effect of short-term rifampin on stable cyclosporine concentrations. Freitag VL; Skifton RD; Lake KD Ann Pharmacother; 1999; 33(7-8):871-2. PubMed ID: 10466920 [No Abstract] [Full Text] [Related]
7. Interaction between cyclosporine and warfarin. Snyder DS Ann Intern Med; 1988 Feb; 108(2):311. PubMed ID: 3124684 [No Abstract] [Full Text] [Related]
8. Cyclosporine nephrotoxicity and cyclosporine--digoxin interaction prior to heart transplantation. Dorian P; Cardella C; Strauss M; David T; East S; Ogilvie R Transplant Proc; 1987 Feb; 19(1 Pt 2):1825-7. PubMed ID: 3274430 [No Abstract] [Full Text] [Related]
9. Effects of rifampin, cyclosporine A, and probenecid on the pharmacokinetic profile of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in healthy participants. Devineni D; Vaccaro N; Murphy J; Curtin C; Mamidi RN; Weiner S; Wang SS; Ariyawansa J; Stieltjes H; Wajs E; Di Prospero NA; Rothenberg P Int J Clin Pharmacol Ther; 2015 Feb; 53(2):115-28. PubMed ID: 25407255 [TBL] [Abstract][Full Text] [Related]
10. Successful use of rifampicin in the treatment of tuberculosis in renal transplant patients immunosuppressed with cyclosporine. al-Sulaiman MH; Dhar JM; al-Khader AA Transplantation; 1990 Oct; 50(4):597-8. PubMed ID: 2219282 [TBL] [Abstract][Full Text] [Related]
12. Rifampicin and cyclosporine dosing in heart transplant recipients. Wandel C; Böhrer H; Böcker R J Cardiothorac Vasc Anesth; 1995 Oct; 9(5):621-2. PubMed ID: 8547575 [No Abstract] [Full Text] [Related]
13. Drug interactions with cyclosporine. Kerr LE Clin Pharm; 1984; 3(4):346, 348. PubMed ID: 6467874 [No Abstract] [Full Text] [Related]
14. Erythromycin and cyclosporine interactions. Springate JE Pediatr Infect Dis; 1986; 5(3):386. PubMed ID: 3725648 [No Abstract] [Full Text] [Related]
15. Cyclosporine interactions with metronidazole and cimetidine. Zylber-Katz E; Rubinger D; Berlatzky Y Drug Intell Clin Pharm; 1988 Jun; 22(6):504-5. PubMed ID: 3293960 [No Abstract] [Full Text] [Related]
16. Isotretinoin treatment of severe cystic acne in a heart transplant patient receiving cyclosporine: consideration of drug interactions. Abel EA J Am Acad Dermatol; 1991 Mar; 24(3):511. PubMed ID: 1829467 [No Abstract] [Full Text] [Related]